213 related articles for article (PubMed ID: 26499410)
1. Incidence of infection-associated cancers in Italy and prevention strategies.
De Flora S; Crocetti E; Bonanni P; Ferro A; Vitale F;
Epidemiol Prev; 2015; 39(4 Suppl 1):14-20. PubMed ID: 26499410
[TBL] [Abstract][Full Text] [Related]
2. Estimates of the future burden of cancer attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():118-127. PubMed ID: 31078165
[TBL] [Abstract][Full Text] [Related]
3. Cancer in Africa 2018: The role of infections.
Parkin DM; Hämmerl L; Ferlay J; Kantelhardt EJ
Int J Cancer; 2020 Apr; 146(8):2089-2103. PubMed ID: 31254479
[TBL] [Abstract][Full Text] [Related]
4. Cancers attributable to infectious agents in Italy.
Collatuzzo G; La Vecchia C; Parazzini F; Alicandro G; Turati F; Di Maso M; Malvezzi M; Pelucchi C; Negri E; Boffetta P
Eur J Cancer; 2023 Apr; 183():69-78. PubMed ID: 36801622
[TBL] [Abstract][Full Text] [Related]
5. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
Hansen BT; Campbell S; Nygård M
BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
[TBL] [Abstract][Full Text] [Related]
6. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
7. Cancers attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():109-117. PubMed ID: 31078164
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of virus infection and human cancer.
Chen CJ; Hsu WL; Yang HI; Lee MH; Chen HC; Chien YC; You SL
Recent Results Cancer Res; 2014; 193():11-32. PubMed ID: 24008291
[TBL] [Abstract][Full Text] [Related]
9. The prevention of infection-associated cancers.
De Flora S; Bonanni P
Carcinogenesis; 2011 Jun; 32(6):787-95. PubMed ID: 21436188
[TBL] [Abstract][Full Text] [Related]
10. Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.
DE Flora S; LA Maestra S; Crocetti E; Mangone L; Bianconi F; Stracci F; Buzzoni C
J Prev Med Hyg; 2019 Dec; 60(4):E311-E326. PubMed ID: 31967088
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for biological agents.
Muñoz N; Bosch FX
IARC Sci Publ; 1997; (142):127-42. PubMed ID: 9354916
[TBL] [Abstract][Full Text] [Related]
12. Infection and cancer: global distribution and burden of diseases.
Oh JK; Weiderpass E
Ann Glob Health; 2014; 80(5):384-92. PubMed ID: 25512154
[TBL] [Abstract][Full Text] [Related]
13. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
14. Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer.
Herrero R; Carvajal LJ; Camargo MC; Riquelme A; Porras C; Ortiz AP; Camargo LA; Fink V; van De Wyngard V; Lazcano-Ponce E; Canelo-Aybar C; Balbin-Ramon G; Feliu A; Espina C
Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102435. PubMed ID: 37852729
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
16. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
17. [Human Papillomavirus infection and vaccination: knowledge and attitudes of Italian general practitioners].
Signorelli C; Odone A; Pezzetti F; Spagnoli F; Visciarelli S; Ferrari A; Camia P; Latini C; Ciorba V; Agodi A; Barchitta M; Scotti S; Misericordia P; Pasquarella C
Epidemiol Prev; 2014; 38(6 Suppl 2):88-92. PubMed ID: 25759351
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
Steele CB; Thomas CN; Richardson LC
J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
[TBL] [Abstract][Full Text] [Related]
20. Anti-viral treatment and cancer control.
Shih WL; Fang CT; Chen PJ
Recent Results Cancer Res; 2014; 193():269-90. PubMed ID: 24008303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
